Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC and BCP for Mandibular Alveolar Ridge Reconstruction
NCT02751125Phase 1Completed
- Sponsor
- University of Bergen
- Start
- Jun 2014
- Primary completion
- Mar 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label trial of autologous mesenchymal stem cells in Alveolar bone atrophy (ABL), sponsored by University of Bergen. Primary endpoint: Amount of newly formed bone at 6 months. Started Jun 2014; status: completed.
02
Drugs
autologous mesenchymal stem cells
03
Conditions
Alveolar bone atrophy (ABL)
Beyond the preview
Go deeper on NCT02751125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02751125.